These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3239423)

  • 1. Renal sympathetic nerve activation in relation to reserpine-induced depletion of neuropeptide Y in the kidney of the rat.
    Pernow J; Thorén P; Millberg BI; Lundberg JM
    Acta Physiol Scand; 1988 Sep; 134(1):53-9. PubMed ID: 3239423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
    Pernow J; Lundberg JM
    Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y and noradrenaline mechanisms in relation to reserpine induced impairment of sympathetic neurotransmission in the cat spleen.
    Lundberg JM; Pernow J; Fried G; Anggärd A
    Acta Physiol Scand; 1987 Sep; 131(1):1-10. PubMed ID: 2890260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.
    Pernow J
    Acta Physiol Scand Suppl; 1988; 568():1-56. PubMed ID: 3232527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reserpine-induced depletion of neuropeptide Y from cardiovascular nerves and adrenal gland due to enhanced release.
    Lundberg JM; Al-Saffar A; Saria A; Theodorsson-Norheim E
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):163-8. PubMed ID: 3010140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms underlying changes in the contents of neuropeptide Y in cardiovascular nerves and adrenal gland induced by sympatholytic drugs.
    Lundberg JM; Saria A; Franco-Cereceda A; Theodorsson-Norheim E
    Acta Physiol Scand; 1985 Aug; 124(4):603-11. PubMed ID: 3840321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of vinblastine on neuropeptide Y levels in the sympathoadrenal system, bone marrow and thrombocytes of the rat.
    Hemsén A; Pernow J; Millberg BI; Lundberg JM
    Agents Actions; 1991 Nov; 34(3-4):429-38. PubMed ID: 1810152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of clonidine and reserpine treatment on neuropeptide Y content in some sympathetically innervated tissues of the guinea-pig.
    Franco-Cereceda A; Nagata M; Svensson TH; Lundberg JM
    Eur J Pharmacol; 1987 Oct; 142(2):267-73. PubMed ID: 3691641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulatory interactions of neuropeptide Y (NPY) on sympathetic neurotransmission.
    Linton-Dahlöf P
    Acta Physiol Scand Suppl; 1989; 586():1-85. PubMed ID: 2557726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-release of neuropeptide Y and catecholamines upon adrenal activation in the cat.
    Lundberg JM; Fried G; Pernow J; Theodorsson-Norheim E
    Acta Physiol Scand; 1986 Feb; 126(2):231-8. PubMed ID: 3754683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated renal and splenic sympathetic nerve stimulation in anaesthetized pigs: maintained overflow of neuropeptide Y in controls but not after reserpine.
    Modin A; Pernow J; Lundberg JM
    J Auton Nerv Syst; 1994 Oct; 49(2):123-34. PubMed ID: 7806765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
    Malmström RE; Lundberg JN; Weitzberg E
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenergic and non-adrenergic mechanisms in sympathetic vascular control of the nasal mucosa.
    Lacroix JS
    Acta Physiol Scand Suppl; 1989; 581():1-63. PubMed ID: 2568728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathetic vascular control of the pig nasal mucosa (III): Co-release of noradrenaline and neuropeptide Y.
    Lacroix JS; Stjärne P; Anggärd A; Lundberg JM
    Acta Physiol Scand; 1989 Jan; 135(1):17-28. PubMed ID: 2911948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y and reserpine-resistant vasoconstriction evoked by sympathetic nerve stimulation in the dog skeletal muscle.
    Pernow J; Kahan T; Lundberg JM
    Br J Pharmacol; 1988 Jul; 94(3):952-60. PubMed ID: 3179619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of reserpine and 6-hydroxydopamine on neuropeptide Y (NPY) and noradrenaline in peripheral neurons.
    Lundberg JM; Saria A; Franco-Cereceda A; Hökfelt T; Terenius L; Goldstein M
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):331-40. PubMed ID: 2858824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y.
    Lundberg JM; Pernow J; Franco-Cereceda A; Rudehill A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S51-68. PubMed ID: 2455193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
    Pernow J; Kahan T; Hjemdahl P; Lundberg JM
    Acta Physiol Scand; 1988 Jan; 132(1):43-50. PubMed ID: 2906210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide.
    Modin A
    Acta Physiol Scand Suppl; 1994; 622():1-74. PubMed ID: 7524267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in circulating levels and cardiovascular tissue content of neuropeptide Y-like immunoreactivity during the development of deoxycorticosterone acetate-salt hypertension in the rat.
    Moreau P; de Champlain J; Yamaguchi N
    J Hypertens; 1992 Aug; 10(8):773-80. PubMed ID: 1325509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.